Erenumab in the Prevention of Migraine Headaches – A Pilot Study
This research aimed to assess the efficiency of erenumab (Aimovig) in the preventive treatment of patients with episodic and chronic migraines. In Croatia, migraine prevention is applied to patients with ≥ 4 days of migraine headaches per month. Prevention efficiency was assessed with the Migrain...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2025-01-01
|
| Edice: | Acta Clinica Croatica |
| Témata: | |
| On-line přístup: | https://hrcak.srce.hr/file/497751 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|